<DOC>
	<DOCNO>NCT00333307</DOCNO>
	<brief_summary>The purpose study determine whether different dos recombinant human relaxin safe give woman severe preeclampsia</brief_summary>
	<brief_title>Evaluation Safety Relaxin Preeclampsia</brief_title>
	<detailed_description>The effect relaxin may beneficial treatment woman preeclampsia . This study preliminarily evaluate maternal , fetal neonatal safety tolerability IV infusion relaxin compare placebo give woman severe preeclampsia .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>Methocarbamol</mesh_term>
	<criteria>Diagnosis preeclampsia Hospital admission expectant management Eclampsia history seizures Vaginal bleeding Multifetal gestation Requirement immediate delivery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>relaxin</keyword>
	<keyword>preeclampsia</keyword>
</DOC>